Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJennifer SnaithPNPhoom NarongkiatikhunPBPetter Bjornstad

Discussion

Loading...

Member takes

Overview

Review highlights potential benefits of integrating technologies and adjunctive therapies for managing type 1 diabetes, suggesting enhancements in outcomes.

Key Points

  • Novel therapies aim to reduce metabolic complications and psychological distress in type 1 diabetes.
  • Emerging evidence shows insulin resistance and inflammation contribute to cardiovascular disease in type 1 diabetes.
  • This review suggests integrating automated glucose monitoring and non-insulin therapies to improve patient outcomes.
  • Large, placebo-controlled trials are necessary to assess the efficacy of combination therapies for individuals with type 1 diabetes.

Cite This Study

Snaith et al. (2025) studied this question.

synapsesocial.com/papers/68c243acb210217d647a8143https://doi.org/10.2337/figshare.29575130.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches2025 · 7 citations
  2. 2Beyond Insulin: Emerging Therapies for Type 1 Diabetes2025
  3. 3Advancements in Diabetes Mellitus: Pathogenesis, Current Therapies, and Emerging Treatment Strategies2025
  4. 4A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus2025 · 15 citations
  5. 5Type 1 diabetes mellitus: retrospect and prospect2024 · 43 citations